This study used radiomics based on T2*-weighted imaging (T2*WI) and neurite orientation dispersion and density imaging (NODDI) to predict the short-term recovery of patients with cervical spondylotic myelopathy (CSM). By classifying patients into good and poor outcomes based on the 3-month recovery rate, we found both T2*WI- and NODDI-based radiomic features to have good prognostic power. Furthermore, radiomic score based on NODDI was an independent predictor, whereas the other features were not. These findings suggest that radiomics based on NODDI has good prognostic power for CSM.
This abstract and the presentation materials are available to members only; a login is required.